NCT Number: NCT02183948
Effect of Oxytocin on Masked Facial Expressions: an fMRI Study
The purpose is to test whether oxytocin has an effect on masked facial expressions
Looking for future studies?
Notify MeKey information
Age range
18 year–29 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Early Phase 1
About this study
The neuropeptide oxytocin (OXT) has been shown to modulate several aspects of human social cognition. Although the exact mechanisms behind these effects remain unclear, recent research suggests that OXT modulates the perception of cues that are important for interpersonal processing, particularly emotional facial expressions. Using a backward masking procedure and functional magnetic resonance imaging, we investigated the modulatory effects of intranasal OXT on the processing of sub-liminally presented emotional faces. In a double-blind placebo-controlled between-subject pharmaco-fMRI experiment healthy volunteers received either 24IU of intranasal oxytocin or placebo 45mins before they were presented emotional (happy, angry, fearful, sad, disgusting) faces and mirror-reversed neutral faces masked by neutral faces of the same individual. To ensure attentional processing of the faces subjects were required to perform a simple gender decision task in the scanner and a recognition memory task afterwards. All subjects were additionally assessed for their state and trait anxiety and depression as well as empathy. For the analysis, we will use matlab, SPM and SPSS to conduct structural ROI analysis and two Sample t test.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Healthy subjects, no smoke or drink alcohol, coffee or other stimulants during the day before Experiment.
Exclusion criteria
- history of head injury; pregnancy; uterine cavity operations were took within one year; medical or psychiatric illness; rhinitis in case they may not fully absorb the spray.
Treatment and study plan
Placebo
DrugPrimary outcomes
-
Number of participants with neuro activity to facial expressions
Time frame: one week
Sponsors and collaborators
Lead sponsor
University of Electronic Science and Technology of China
Other
Registry information
Important dates
- Study start
- 2014
- Primary completion
- 2014
- Study completion
- 2014
- First posted
- Jul 8, 2014
- Registry last updated
- Mar 7, 2017
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Efficiency of Sonic Activation During Root Canal Treatment of Primary Molars on Postoperative Pain and Facial Expressions
NCT07138937
Artificial Intelligence Mobile Application, Behavior
Ismailia, Egypt
View Trial DetailsPreliminary Research Using Artificial Intelligence Technology to Identify Differences in Facial Expressions Between Healthy People, Patients With Cognitive Decline, and Patients With Dementia
NCT06513403
Artificial Intelligence Technology, Behavior
Hsinchu, Taiwan
View Trial DetailsImpact of OnabotulinumtoxinA (BOTOX®) on Stress
NCT06778421
Behavior, Behavioral Symptoms
Beverly Hills, California, United States
View Trial DetailsComparison of the Effects of Two Frequencies of Application of Photobiomodulation on Facial Rejuvenation
NCT04911140
Behavior, Communication
São Paulo, Brazil
View Trial Details